1 – 10 of 246
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Associations of modifiable and non-modifiable risk factors with longitudinal white matter hyperintensities, amyloid-β and tau - a prospective cohort study
(2026) In The journal of prevention of Alzheimer's disease
- Contribution to journal › Article
-
Mark
Integration of plasma eMTBR-tau243 and p-tau217 in the diagnosis and stratification of Alzheimer's disease : a prospective cohort study
- Contribution to journal › Article
-
Mark
Identification of distinct and shared biomarker panels in different manifestations of cerebral small-vessel disease through proteomic profiling
- Contribution to journal › Article
-
Mark
Blood and CSF Biomarkers in Amyotrophic Lateral Sclerosis: Diagnostic and Prognostic Insights from a Systematic Review and Meta-analysis
(2026) AD/PD 2026
- Contribution to conference › Poster
-
Mark
Eligibility for amyloid targeting therapies among primary care patients with cognitive symptoms
- Contribution to journal › Article
-
Mark
Plasma pTau 217/β-amyloid 1–42 ratio for enhanced accuracy and reduced uncertainty in detecting amyloid pathology
- Contribution to journal › Article
-
Mark
Alzheimer's disease Stage 1 and 2 : Biology, diagnostics, and treatment
- Contribution to journal › Scientific review
-
Mark
A deep joint-learning proteomics model for diagnosis of six conditions associated with dementia
(2026) In Nature Medicine
- Contribution to journal › Article
-
Mark
The Role of Clinical, Plasma, and Imaging Biomarkers in Assessing Future Dementia Risk in Individuals With Subjective Cognitive Decline
- Contribution to journal › Article
- 2025
-
Mark
APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-beta
- Contribution to journal › Article
